NCM
Nantahala Capital Management’s Spyre Therapeutics SYRE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-4,101,193
| Closed | -$1.85M | – | 125 |
|
|
2023
Q2 | $1.85M | Sell |
4,101,193
-456,819
| -10% | -$206K | 0.18% | 67 |
|
|
2023
Q1 | $1.32M | Sell |
4,558,012
-53,290
| -1% | -$15.5K | 0.1% | 79 |
|
|
2022
Q4 | $2.07M | Buy |
4,611,302
+900,524
| +24% | +$405K | 0.13% | 65 |
|
|
2022
Q3 | $1.95M | Sell |
3,710,778
-166,533
| -4% | -$87.6K | 0.13% | 63 |
|
|
2022
Q2 | $1.96M | Buy |
3,877,311
+676,718
| +21% | +$342K | 0.1% | 67 |
|
|
2022
Q1 | $7.36M | Buy |
3,200,593
+387,033
| +14% | +$890K | 0.33% | 43 |
|
|
2021
Q4 | $13.4M | Buy |
2,813,560
+1,296,605
| +85% | +$6.16M | 0.47% | 33 |
|
|
2021
Q3 | $12.1M | Sell |
1,516,955
-160,081
| -10% | -$1.27M | 0.38% | 40 |
|
|
2021
Q2 | $11.7M | Sell |
1,677,036
-35,052
| -2% | -$244K | 0.33% | 46 |
|
|
2021
Q1 | $13.6M | Sell |
1,712,088
-262,214
| -13% | -$2.08M | 0.4% | 40 |
|
|
2020
Q4 | $15.5M | Sell |
1,974,302
-1,149,128
| -37% | -$9.04M | 0.48% | 40 |
|
|
2020
Q3 | $22.1M | Sell |
3,123,430
-81,400
| -3% | -$577K | 0.68% | 24 |
|
|
2020
Q2 | $29.6M | Buy |
3,204,830
+352,570
| +12% | +$3.26M | 0.89% | 19 |
|
|
2020
Q1 | $13.1M | Hold |
2,852,260
| – | – | 0.49% | 29 |
|
|
2019
Q4 | $21.8M | Hold |
2,852,260
| – | – | 0.67% | 25 |
|
|
2019
Q3 | $21.9M | Hold |
2,852,260
| – | – | 0.81% | 20 |
|
|
2019
Q2 | $19.5M | Buy |
2,852,260
+200,000
| +8% | +$1.37M | 0.6% | 28 |
|
|
2019
Q1 | $21.4M | Buy |
2,652,260
+125,000
| +5% | +$1.01M | 0.67% | 24 |
|
|
2018
Q4 | $18.9M | Hold |
2,527,260
| – | – | 0.58% | 27 |
|
|
2018
Q3 | $24.2M | Buy |
2,527,260
+314,208
| +14% | +$3.01M | 0.65% | 23 |
|
|
2018
Q2 | $23.4M | Buy |
2,213,052
+368,379
| +20% | +$3.9M | 0.95% | 19 |
|
|
2018
Q1 | $18.3M | Hold |
1,844,673
| – | – | 0.82% | 21 |
|
|
2017
Q4 | $9.98M | Buy |
1,844,673
+241,770
| +15% | +$1.31M | 0.44% | 27 |
|
|
2017
Q3 | $7.9M | Buy |
1,602,903
+10,000
| +0.6% | +$49.3K | 0.39% | 25 |
|
|
2017
Q2 | $6.13M | Buy |
+1,592,903
| New | +$6.13M | 0.49% | 25 |
|